Article
The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
Clinical and experimental rheumatology - 1 Jan 2000
Park Yune-Jung, Yoo Seung-Ah, Lee Jeong-Hwa, Chung Yeun-Jun, Cho Chul-Soo, Kim Wan -Uk
Abstract excerpt
OBJECTIVES: A decrease in high-density lipoprotein (HDL) cholesterol during inflammation is common in many rheumatologic diseases, including rheumatoid arthritis (RA). Apolipoprotein M (apoM) is an apolipoprotein predominantly associated with HDL cholesterol. Recently, apoM polymorphisms have bee...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
